Advertisement

Topics

NHGRI contributes to study that implicates 63 new gene variants in prostate cancer risk

20:00 EDT 11 Jun 2018 | National Genome Research


Elaine A. Ostrander, Ph.D., a researcher with the National Human Genome Research Institute, contributed to a new study that has implicated 63 additional genetic variants in prostate cancer risk. Dr. Ostrander and her colleagues based their findings, published in Nature Genetics, on DNA samples from more than 140,000 men.

Original Article: NHGRI contributes to study that implicates 63 new gene variants in prostate cancer risk

NEXT ARTICLE

More From BioPortfolio on "NHGRI contributes to study that implicates 63 new gene variants in prostate cancer risk"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...